{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:19:14Z","timestamp":1783189154777,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100030969","name":"Sociedad Madrile\u00f1a de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","award":["169-2022"],"award-info":[{"award-number":["169-2022"]}],"id":[{"id":"10.13039\/100030969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PI22\/00766"],"award-info":[{"award-number":["PI22\/00766"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eimce.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:04:11Z","timestamp":1762009451000},"page":"607-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rifapentine-based treatment of tuberculosis infection in Spanish adolescents"],"prefix":"10.1016","volume":"43","author":[{"given":"Antoni","family":"Noguera-Julian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Latre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garcia-Rebollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Peraita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e0udia","family":"Fortuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2025.09.004_bib0095","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-054663","article-title":"Tuberculosis infection in children and adolescents: testing and treatment","volume":"148","author":"Nolt","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimce.2025.09.004_bib0100","series-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.eimce.2025.09.004_bib0105","first-page":"157","article-title":"Rifapentine's long and winding road to European patients","volume":"21","author":"Castro","year":"2022","journal-title":"Enf Emerg"},{"key":"10.1016\/j.eimce.2025.09.004_bib0110","doi-asserted-by":"crossref","first-page":"2200388","DOI":"10.1183\/13993003.00388-2022","article-title":"Rifapentine access in Europe: growing concerns over key tuberculosis treatment component","volume":"59","author":"Guglielmetti","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eimce.2025.09.004_bib0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.anpedi.2023.03.011","article-title":"Update on the diagnosis and treatment of tuberculosis","volume":"98","author":"Baquero-Artigao","year":"2023","journal-title":"An Pediatr (Engl Ed)"},{"key":"10.1016\/j.eimce.2025.09.004_bib0120","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Medicamentos en situaciones especiales [Medications in special situations]. Madrid, Spain. Available from: https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/acceso-a-medicamentos-en-situaciones-especiales\/?lang=va [accessed 23.4.25]."},{"key":"10.1016\/j.eimce.2025.09.004_bib0125","series-title":"Tuberculosis preventive treatment dosing information [Internet]","year":"2023"},{"key":"10.1016\/j.eimce.2025.09.004_bib0130","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2025.09.004_bib0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.eimce.2025.09.004_bib0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis","volume":"380","author":"Swindells","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2025.09.004_bib0145","series-title":"WHO operational handbook on tuberculosis. Module 5: management of tuberculosis in children and adolescents","year":"2022"},{"key":"10.1016\/j.eimce.2025.09.004_bib0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S2352-4642(19)30337-2","article-title":"Adolescent tuberculosis","volume":"4","author":"Snow","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.eimce.2025.09.004_bib0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.anpedi.2023.01.013","article-title":"Adolescence, multidrug resistant tuberculosis, bedaquiline and videotapes","volume":"99","author":"Gamell","year":"2023","journal-title":"An Pediatr (Engl Ed)"},{"key":"10.1016\/j.eimce.2025.09.004_bib0160","doi-asserted-by":"crossref","first-page":"e0012565","DOI":"10.1371\/journal.pntd.0012565","article-title":"Video-observed therapy (VOT) vs directly observed therapy (DOT) for tuberculosis treatment: a systematic review on adherence, cost of treatment observation, time spent observing treatment and patient satisfaction","volume":"18","author":"Areas Lisboa Netto","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.eimce.2025.09.004_bib0165","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1128\/AAC.05128-14","article-title":"Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers","volume":"59","author":"Dooley","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2025.09.004_bib0170","doi-asserted-by":"crossref","first-page":"2201227","DOI":"10.1183\/13993003.01227-2022","article-title":"Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally","volume":"60","author":"Masini","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eimce.2025.09.004_bib0175","doi-asserted-by":"crossref","first-page":"2400104","DOI":"10.1183\/13993003.00104-2024","article-title":"Availability of paediatric dispersible fixed-dose combinations of tuberculosis drugs in Spain","volume":"63","author":"Noguera-Julian","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eimce.2025.09.004_bib0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.anpedi.2024.04.008","article-title":"Dispersible fixed-dose combinations of antituberculous drugs. Finally available!!","volume":"101","author":"Noguera-Julian","year":"2024","journal-title":"An Pediatr (Engl Ed)"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X25001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X25001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:05:44Z","timestamp":1783188344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X25001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2529993X25001728"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2025.09.004","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifapentine-based treatment of tuberculosis infection in Spanish adolescents","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}